📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
ALEMBIC PHARMACEUTICALS LIMITEDAPLLTDPharmaceuticals
Open
704.2
High
709.65
Low
692.65
Close
703.3
Volume
24838
Exchange
nse
Time
12-Mar-2026

Outlook

Score:

2.25

Rating:

RISKY

Candlestick Pattern

CandlepatternofAlembicPharmaceuticalsis
High Wave
EstimatedStoplossofAlembicPharmaceuticalsis
709.65
AlembicPharmaceuticalshasa
Bearishℹ
pattern.
Formationof
High Wave
candlepatternindicatesthetrenddirectionofAlembicPharmaceuticalsis
Unpredictableℹ
.

Trend

AlembicPharmaceuticalsisin
Sideways trendℹ
.
PriceofAlembicPharmaceuticalsis
Downℹ
by

7.72

%.
Target
Buy@

690.91

Sell@

882.83

Current@

703.3

Volume

ThetradevolumesofAlembicPharmaceuticalshavebecome
Deficientℹ
ThevolumetrendforAlembicPharmaceuticalsis
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofAlembicPharmaceuticalsis

Down

by

56.14

%

Valuation

ThecurrentmarketpriceofAlembicPharmaceuticalsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth7772crandtotalassetsworth7772cr,thebalancesheetofAlembicPharmaceuticalsis:
Balancedℹ
.
Cashflow
AlembicPharmaceuticalshas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 36cr

.Itis
Downℹ
by

181.82

%.
7.92% i.e. ₹ 87cr earned in operatingℹ
51.73% i.e. ₹ 568cr spent in investingℹ
40.35% i.e. ₹ 443cr earned in financingℹ
0% in otherℹ
AlembicPharmaceuticalshas
Excellentℹ
cashflowbecausethereis

Surplus

of

₹ 44cr

.Itis
Upℹ
by

214.29

%.
51.47% i.e. ₹ 803cr earned in operatingℹ
20.51% i.e. ₹ 320cr spent in investingℹ
28.01% i.e. ₹ 437cr spent in financingℹ
0% in otherℹ
Income
TheincomeofAlembicPharmaceuticalsis

₹ 1917cr

and

Profit

is:

₹ 182cr

AlembicPharmaceuticalsProfitisupby:

18.18

%andIncomeisUpby:

11.65

%
TheincomeofAlembicPharmaceuticalsis

₹ 1717cr

and

Profit

is:

₹ 154cr

AlembicPharmaceuticalsProfitisdownby:

1.91

%andIncomeisDownby:

3.7

%
TheincomeofAlembicPharmaceuticalsis

₹ 1783cr

and

Profit

is:

₹ 157cr

AlembicPharmaceuticalsProfitisupby:

14.6

%andIncomeisUpby:

4.76

%
By using this site you agree to the use of cookies to deliver a better site experience.